Table 2.
Tumor biomarkers of the patient specimens analyzed
| No mets | Mets | |
|---|---|---|
| Number (%) | Number (%) | |
| Total number | 17 | 13 |
| ER+ | 6 (35) | 3 (23) |
| Her2+ | 2 (12) | 4 (30) |
| ER+/Her+ | 1 (5) | 0 (0) |
| TN | 8 (47) | 6 (46) |
Tumor biomarkers of the patient specimens analyzed
| No mets | Mets | |
|---|---|---|
| Number (%) | Number (%) | |
| Total number | 17 | 13 |
| ER+ | 6 (35) | 3 (23) |
| Her2+ | 2 (12) | 4 (30) |
| ER+/Her+ | 1 (5) | 0 (0) |
| TN | 8 (47) | 6 (46) |